Themac Resources Reminds Shareholders to Vote in Advance of Upcoming Special Meeting

Executive Summary

• THEMAC Resources Group Limited reminds shareholders to vote on the special resolution approving a statutory plan of arrangement under which Tulla Resources Group Pty. Ltd. will acquire all outstanding common shares not already owned by Tulla for cash consideration of $0.08 per share.
• The Board has unanimously approved the Arrangement (with two directors abstaining) and ISS recommends voting FOR the Arrangement.
• Shareholders must submit proxy votes by 9:00 a.m. PT on October 3, 2025; the special meeting is scheduled for October 7, 2025 at 9:00 a.m. PT in Vancouver.

Key Details

• Arrangement Overview: Tulla will acquire all THEMAC common shares not already owned by Tulla via a statutory plan of arrangement under the Yukon Business Corporations Act.
• Consideration: Cash payment of $0.08 per share to each non‑Tulla shareholder.
• Board Position: Unanimous approval (Kevin Maloney and Andrew Maloney abstained).
• Proxy Advisory Recommendation: Institutional Shareholder Services Inc. (ISS) recommends shareholders vote FOR the Arrangement.
• Meeting Information:
• Date & Time: Tuesday, October 7, 2025 at 9:00 a.m. PT
• Location: 1500 - 1055 West Georgia Street, Vancouver, BC, Canada (V6E 4N7)
• Proxy Voting Deadline: October 3, 2025 at 9:00 a.m. PT.
• Voting Instructions: Shareholders encouraged to vote online or by telephone due to the Canada Post strike; contact Carson Proxy for assistance.
• Document Delivery: In light of the strike, shareholders should use courier services or hand‑deliver documents to Computershare Investor Services Inc., 320 Bay Street, 14th Floor, Toronto, ON (M5H 4A6).

Notable Quotes

“The Arrangement is in the best interests of the Company and is fair to Shareholders.” – Board statement (Kevin Maloney & Andrew Maloney abstaining)

Materiality Assessment: Material – Neutral (the announcement pertains to a pending transaction that could significantly affect shareholders, but no definitive outcome has yet been reported).